Here’s what ML and NLP powered in capital markets in 2022

As machine learning and natural language processing continue to spread across the industry, WatersTechnology highlights stories from 2022 that feature new use cases.

Innovation is the name of the game, especially in the capital markets. And two prominent tools behind innovative developments are machine learning (ML) and natural language processing (NLP).

The use of AI is rapidly growing in all facets of life, including trading. It’s growing so fast, in fact, that regulators including the Bank of England and the Dutch AFM have raised concerns about the possibility that machine learning trading algorithms could ‘learn’ to collude. Quants are also questioning

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

Register for free

Access two articles, our IMD and Waters Wraps, plus a member newsletter. Find out more.

All fields are mandatory unless otherwise highlighted.

This address will be used to create your account

A tech revolution in an old-school industry: FX

FX is in a state of transition, as asset managers and financial firms explore modernizing their operating processes. But manual processes persist. MillTechFX’s Eric Huttman makes the case for doubling down on new technology and embracing automation to increase operational efficiency in FX.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here